Literature DB >> 23329006

Immediate adenoidectomy vs initial watchful waiting strategy in children with recurrent upper respiratory tract infections: an economic evaluation.

Chantal W B Boonacker1, Maaike T A van den Aardweg, Pieter H Broos, Arno W Hoes, Anne G M Schilder, Maroeska M Rovers.   

Abstract

OBJECTIVE: To compare the costs associated with 2 clinical strategies in children with recurrent upper respiratory tract infections (URTIs): immediate adenoidectomy vs an initial watchful waiting strategy.
DESIGN: A cost-minimization analysis from a societal perspective including both direct and indirect costs, alongside an open randomized controlled trial with a 2-year follow-up.
SETTING: Multicenter study, including 11 general and 2 university hospitals in the Netherlands. PATIENTS: The study population comprised 111 children aged 1 through 6 years, selected for adenoidectomy for recurrent URTIs according to current clinical practice. INTERVENTION: A strategy of immediate adenoidectomy with or without myringotomy or a strategy of initial watchful waiting. MAIN OUTCOMES MEASURES: Difference in median costs during the 2-year follow-up.
RESULTS: The median total of direct and indirect costs in the adenoidectomy and watchful waiting group were €1385 (US $1995) and €844 (US $1216) per patient, respectively. The extra costs in the adenoidectomy group are primarily attributable to surgery and visits to the otorhinolaryngologist. Other costs did not differ significantly between the groups.
CONCLUSIONS: In children selected for adenoidectomy for recurrent URTIs, immediate adenoidectomy results in an increase in costs, whereas it confers no clinical benefit over an initial watchful waiting strategy. TRIAL REGISTRATION: trialregister.nl Identifier:NTR968; isrctn.org Identifier:ISRCTN03720485.

Entities:  

Mesh:

Year:  2013        PMID: 23329006     DOI: 10.1001/jamaoto.2013.1324

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  3 in total

1.  Changes in healthcare utilisation for paediatric tonsillectomy and adenoidectomy in the Netherlands: a population-based study.

Authors:  Juliëtte J C M van Munster; Amir H Zamanipoor Najafabadi; Janneke van 't Hooft; Teus A van Barneveld; Stefan Böhringer; Jorrit S Visser; Rolf H Bremmer; Wilco C Peul; Wilbert B van den Hout; Peter Paul G van Benthem
Journal:  Clin Otolaryngol       Date:  2020-12-13       Impact factor: 2.597

2.  Regional and hospital variation in commonly performed paediatric otolaryngology procedures in the Netherlands: a population-based study of healthcare utilisation between 2016 and 2019.

Authors:  Juliëtte J C M van Munster; Joost J G Wammes; Rolf H Bremmer; Amir H Zamanipoor Najafabadi; Raphael J Hemler; Wilco C Peul; Wilbert B van den Hout; Peter Paul G van Benthem
Journal:  BMJ Open       Date:  2021-07-01       Impact factor: 2.692

3.  The cost-effectiveness analysis of drug therapy versus surgery for symptomatic adenoid hypertrophy by a Markov model.

Authors:  Han Xiao; Jinqiang Huang; Weifeng Liu; Zihao Dai; Sui Peng; Zhenwei Peng; Ruiming Liang; Renqiang Ma; Yihui Wen; Jian Li; Weiping Wen
Journal:  Qual Life Res       Date:  2019-11-28       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.